Global Antibody-drug Conjugate Market Research Report 2020

Global Antibody-drug Conjugate Market Research Report 2020

Table of Contents
1 Antibody-drug Conjugate Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugate
1.2 Antibody-drug Conjugate Segment by Type
1.2.1 Global Antibody-drug Conjugate Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugate Segment by Application
1.3.1 Antibody-drug Conjugate Sales Comparison by Application: 2020 VS 2026
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugate Market Size Estimates and Forecasts
1.4.1 Global Antibody-drug Conjugate Revenue 2015-2026
1.4.2 Global Antibody-drug Conjugate Sales 2015-2026
1.4.3 Antibody-drug Conjugate Market Size by Region: 2020 Versus 2026
2 Global Antibody-drug Conjugate Market Competition by Manufacturers
2.1 Global Antibody-drug Conjugate Sales Market Share by Manufacturers (2015-2020)
2.2 Global Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
2.3 Global Antibody-drug Conjugate Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Antibody-drug Conjugate Manufacturing Sites, Area Served, Product Type
2.5 Antibody-drug Conjugate Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugate Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Antibody-drug Conjugate Players (Opinion Leaders)
3 Antibody-drug Conjugate Retrospective Market Scenario by Region
3.1 Global Antibody-drug Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Antibody-drug Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Antibody-drug Conjugate Market Facts & Figures by Country
3.3.1 North America Antibody-drug Conjugate Sales by Country
3.3.2 North America Antibody-drug Conjugate Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody-drug Conjugate Market Facts & Figures by Country
3.4.1 Europe Antibody-drug Conjugate Sales by Country
3.4.2 Europe Antibody-drug Conjugate Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody-drug Conjugate Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody-drug Conjugate Sales by Region
3.5.2 Asia Pacific Antibody-drug Conjugate Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody-drug Conjugate Market Facts & Figures by Country
3.6.1 Latin America Antibody-drug Conjugate Sales by Country
3.6.2 Latin America Antibody-drug Conjugate Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Antibody-drug Conjugate Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody-drug Conjugate Sales by Country
3.7.2 Middle East and Africa Antibody-drug Conjugate Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibody-drug Conjugate Historic Market Analysis by Type
4.1 Global Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
4.2 Global Antibody-drug Conjugate Revenue Market Share by Type (2015-2020)
4.3 Global Antibody-drug Conjugate Price Market Share by Type (2015-2020)
4.4 Global Antibody-drug Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Antibody-drug Conjugate Historic Market Analysis by Application
5.1 Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
5.2 Global Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
5.3 Global Antibody-drug Conjugate Price by Application (2015-2020)
6 Company Profiles and Key Figures in Antibody-drug Conjugate Business
6.1 Agensys
6.1.1 Corporation Information
6.1.2 Agensys Description, Business Overview and Total Revenue
6.1.3 Agensys Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Agensys Products Offered
6.1.5 Agensys Recent Development
6.2 Concortis Biotherapeutics
6.2.1 Concortis Biotherapeutics Antibody-drug Conjugate Production Sites and Area Served
6.2.2 Concortis Biotherapeutics Description, Business Overview and Total Revenue
6.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Concortis Biotherapeutics Products Offered
6.2.5 Concortis Biotherapeutics Recent Development
6.3 Sanofi
6.3.1 Sanofi Antibody-drug Conjugate Production Sites and Area Served
6.3.2 Sanofi Description, Business Overview and Total Revenue
6.3.3 Sanofi Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi Products Offered
6.3.5 Sanofi Recent Development
6.4 Celldex Therapeutics
6.4.1 Celldex Therapeutics Antibody-drug Conjugate Production Sites and Area Served
6.4.2 Celldex Therapeutics Description, Business Overview and Total Revenue
6.4.3 Celldex Therapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Celldex Therapeutics Products Offered
6.4.5 Celldex Therapeutics Recent Development
6.5 Synthon Holding BV
6.5.1 Synthon Holding BV Antibody-drug Conjugate Production Sites and Area Served
6.5.2 Synthon Holding BV Description, Business Overview and Total Revenue
6.5.3 Synthon Holding BV Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Synthon Holding BV Products Offered
6.5.5 Synthon Holding BV Recent Development
7 Antibody-drug Conjugate Manufacturing Cost Analysis
7.1 Antibody-drug Conjugate Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody-drug Conjugate
7.4 Antibody-drug Conjugate Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody-drug Conjugate Distributors List
8.3 Antibody-drug Conjugate Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Antibody-drug Conjugate Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody-drug Conjugate by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Antibody-drug Conjugate by Type (2021-2026)
10.2 Antibody-drug Conjugate Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody-drug Conjugate by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Antibody-drug Conjugate by Application (2021-2026)
10.3 Antibody-drug Conjugate Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody-drug Conjugate by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Antibody-drug Conjugate by Region (2021-2026)
10.4 North America Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.5 Europe Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.6 Asia Pacific Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.7 Latin America Antibody-drug Conjugate Estimates and Projections (2021-2026)
10.8 Middle East and Africa Antibody-drug Conjugate Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antibody-drug Conjugate Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Antibody-drug Conjugate Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Antibody-drug Conjugate Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Antibody-drug Conjugate Manufacturers Covered in This Study
Table 5. Global Antibody-drug Conjugate Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Antibody-drug Conjugate Sales Share by Manufacturers (2015-2020)
Table 7. Global Antibody-drug Conjugate Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Antibody-drug Conjugate Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Antibody-drug Conjugate Sales Sites and Area Served
Table 11. Manufacturers Antibody-drug Conjugate Product Types
Table 12. Global Antibody-drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibody-drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugate as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Antibody-drug Conjugate Players
Table 16. Global Antibody-drug Conjugate Sales (K Units) by Region (2015-2020)
Table 17. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Table 18. Global Antibody-drug Conjugate Revenue (Million US$) by Region (2015-2020)
Table 19. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Table 20. North America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 21. North America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 22. North America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 24. Europe Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 25. Europe Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 26. Europe Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Antibody-drug Conjugate Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Antibody-drug Conjugate Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Table 32. Latin America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 33. Latin America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 34. Latin America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 40. Global Antibody-drug Conjugate Sales (K Units) by Type (2015-2020)
Table 41. Global Antibody-drug Conjugate Sales Share by Type (2015-2020)
Table 42. Global Antibody-drug Conjugate Revenue (Million US$) by Type (2015-2020)
Table 43. Global Antibody-drug Conjugate Revenue Share by Type (2015-2020)
Table 44. Global Antibody-drug Conjugate Price (USD/Unit) by Type (2015-2020)
Table 45. Global Antibody-drug Conjugate Sales (K Units) by Application (2015-2020)
Table 46. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Table 47. Global Antibody-drug Conjugate Sales Growth Rate by Application (2015-2020)
Table 48. Agensys Antibody-drug Conjugate Corporation Information
Table 49. Agensys Description and Business Overview
Table 50. Agensys Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Agensys Main Product
Table 52. Agensys Recent Development
Table 53. Concortis Biotherapeutics Antibody-drug Conjugate Corporation Information
Table 54. Concortis Biotherapeutics Corporation Information
Table 55. Concortis Biotherapeutics Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Concortis Biotherapeutics Main Product
Table 57. Concortis Biotherapeutics Recent Development
Table 58. Sanofi Antibody-drug Conjugate Corporation Information
Table 59. Sanofi Corporation Information
Table 60. Sanofi Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Sanofi Main Product
Table 62. Sanofi Recent Development
Table 63. Celldex Therapeutics Antibody-drug Conjugate Corporation Information
Table 64. Celldex Therapeutics Corporation Information
Table 65. Celldex Therapeutics Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Celldex Therapeutics Main Product
Table 67. Celldex Therapeutics Recent Development
Table 68. Synthon Holding BV Antibody-drug Conjugate Corporation Information
Table 69. Synthon Holding BV Corporation Information
Table 70. Synthon Holding BV Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Synthon Holding BV Main Product
Table 72. Synthon Holding BV Recent Development
Table 73. Sales Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Antibody-drug Conjugate Distributors List
Table 76. Antibody-drug Conjugate Customers List
Table 77. Market Key Trends
Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 79. Key Challenges
Table 80. Global Antibody-drug Conjugate Sales (K Units) Forecast by Type (2021-2026)
Table 81. Global Antibody-drug Conjugate Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Antibody-drug Conjugate Revenue (Million US$) Forecast by Type (2021-2026)
Table 83. Global Antibody-drug Conjugate Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 84. Global Antibody-drug Conjugate Sales (K Units) Forecast by Application (2021-2026)
Table 85. Global Antibody-drug Conjugate Revenue (Million US$) Forecast by Application (2021-2026)
Table 86. Global Antibody-drug Conjugate Sales (K Units) Forecast by Region (2021-2026)
Table 87. Global Antibody-drug Conjugate Sales Market Share Forecast by Region (2021-2026)
Table 88. Global Antibody-drug Conjugate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 89. Global Antibody-drug Conjugate Revenue Market Share Forecast by Region (2021-2026)
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Antibody-drug Conjugate
Figure 2. Global Antibody-drug Conjugate Sales Market Share by Type: 2020 VS 2026
Figure 3. Adcetris Product Picture
Figure 4. Kadcyla Product Picture
Figure 5. Global Antibody-drug Conjugate Consumption Market Share by Application: 2020 VS 2026
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Global Antibody-drug Conjugate Market Size 2015-2026 (US$ Million)
Figure 9. Global Antibody-drug Conjugate Sales Capacity (K Units) (2015-2026)
Figure 10. Global Antibody-drug Conjugate Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Antibody-drug Conjugate Sales Share by Manufacturers in 2020
Figure 12. Global Antibody-drug Conjugate Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Antibody-drug Conjugate Revenue in 2019
Figure 14. Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Figure 16. Global Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 17. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Figure 18. Global Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 19. North America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 20. North America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 21. U.S. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 26. Europe Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 27. Germany Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 38. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 39. China Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 62. Latin America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 63. Mexico Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 71. Turkey Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Antibody-drug Conjugate by Type (2015-2020)
Figure 78. Sales Market Share of Antibody-drug Conjugate by Type in 2019
Figure 79. Revenue Share of Antibody-drug Conjugate by Type (2015-2020)
Figure 80. Revenue Market Share of Antibody-drug Conjugate by Type in 2019
Figure 81. Global Antibody-drug Conjugate Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Figure 83. Global Antibody-drug Conjugate Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Antibody-drug Conjugate by Application (2015-2020)
Figure 85. Global Revenue Share of Antibody-drug Conjugate by Application in 2020
Figure 86. Agensys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Concortis Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Celldex Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Synthon Holding BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Price Trend of Key Raw Materials
Figure 92. Manufacturing Cost Structure of Antibody-drug Conjugate
Figure 93. Manufacturing Process Analysis of Antibody-drug Conjugate
Figure 94. Antibody-drug Conjugate Industrial Chain Analysis
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Porter's Five Forces Analysis
Figure 98. North America Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 99. North America Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 100. Europe Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 101. Europe Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Latin America Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 103. Latin America Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Middle East and Africa Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. Middle East and Africa Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Asia Pacific Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Asia Pacific Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs